Skip to content

Clinical trials

Carcinoma, Renal Cell trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Renal Cell Country / region: Russia Clear all

64 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20044
20052
20065
20073
20084
20092
20102
20112
20121
20131
20141
20151
20166
20179
20181
20194
20207
20216

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed46
Active, not recruiting9
Unknown status5
Terminated3
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Kidney Cancer Research Bureau9
Bristol-Myers Squibb6
Hoffmann-La Roche6
Merck Sharp & Dohme LLC6
Pfizer6
Bayer4
Novartis Pharmaceuticals4
Biocad2
Eisai Inc.2
GlaxoSmithKline2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell64
Kidney Neoplasms16
Neoplasms7
Melanoma5
Neoplasm Metastasis4
Carcinoma3
Carcinoma, Non-Small-Cell Lung3
Lung Neoplasms3
Adenocarcinoma2
Carcinoma, Transitional Cell2

Trials

Showing 1 to 25 of 64. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.